Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10
Published December 24, 2025 · Recall initiated: November 26, 2025
Summary
FDA records drug Class II recall D-0235-2026, published December 24, 2025 and initiated November 26, 2025. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 2472 HDPE Bottles; Lot: Lot GS065762. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules
What to do
Voluntary: Firm initiated · Letter
Get an email if BACLOFEN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BACLOFEN
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- Nationwide within the USA
- Lot
- Lot GS065762
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4December 24, 2025
- FDACisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only,December 24, 2025
- FDACook-Walte, Carbocaine 3% (30 mg/mL), (mepivacaine hydrochloride Injection, USP), packaged in a cartonDecember 24, 2025
- FDACisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only,December 24, 2025
- FDABenco dental Graham CHEMICAL CO., Mepivacaine HCI 3% (30 mg/mL) Injection, [Mepivacaine HCI Injection, USP],December 24, 2025
- FDACisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, RxDecember 24, 2025
Questions about this recall
Was Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10 recalled?
Yes. FDA published recall D-0235-2026 on December 24, 2025. Reported hazard: Presence of Foreign Tablets/Capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BACLOFEN.